Whitfield Dianne C. sold TARS
December 16, 2025 · Form 4 insider transaction
Whitfield Dianne C. sold 7,397 shares of Tarsus Pharmaceuticals, Inc. at $80.10 per share, a transaction worth $592.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,397
Price
$80.10
Total value
$592.5K
InsiderWhitfield Dianne C.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after38,958
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.